Long-term follow-up consistent with earlier report, a hint of benefit in high-grade diseas ...

Using de-identified data from the National Cancer Institute, researchers followed 205 patients—average age, 61 years—with prostate cancer and preexisting depression. Patients with both conditions had ...

U.S. study supports findings from a global trial using an external control arm ...

The ARASEC study prospectively examined darolutamide plus ADT in US men with mHSPC, but used a historical control group receiving ADT monotherapy from the phase 3 CHAARTED trial for matching and ...

Add Yahoo as a preferred source to see more of our stories on Google. If a person has an "aggressive" prostate cancer with a Gleason score of 9, what does that mean? What's the outlook when it comes ...

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

Researchers with the James P. Allison Institute at The University of Texas MD Anderson Cancer Center have discovered a new ...

These results correspond to an 80% reduction in the risk of death among patients surviving beyond five years.

Please provide your email address to receive an email when new articles are posted on . Men who have depression before prostate cancer diagnosis may have significantly greater risk for death than ...

Excess body weight, as measured by BMI, is associated with improved overall survival (OS) in men with advanced prostate cancer, particularly those with metastatic castration-resistant disease, a ...

Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...